The roles of sodium-glucose cotransporter 2 inhibitors in preventing kidney injury in diabetes

The roles of sodium-glucose cotransporter 2 inhibitors in preventing kidney injury in diabetes

© 2017 Elsevier Masson SAS Diabetic nephropathy (DN) is the leading cause of end stage renal disease (ESRD) worldwide. The early effective treatment of high plasma glucose could delay or prevent the onset of DN. Sodium-glucose cotransporter 2 (SGLT2) inhibitors are new target treatments for ameliora...

Saved in:

書目詳細資料
Main Authors:	Jaikumkao K., Pongchaidecha A., Chatsudthipong V., Chattipakorn S., Chattipakorn N., Lungkaphin A.
格式:	雜誌
出版:	2017
在線閱讀:	https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85026376186&origin=inward http://cmuir.cmu.ac.th/jspui/handle/6653943832/40092
標簽:	添加標簽沒有標簽, 成為第一個標記此記錄!

相似書籍

The roles of sodium-glucose cotransporter 2 inhibitors in preventing kidney injury in diabetes
由: Krit Jaikumkao, et al.
出版: (2018)

The roles of sodium-glucose cotransporter 2 inhibitors in preventing kidney injury in diabetes
由: Krit Jaikumkao, et al.
出版: (2018)

Renal outcomes with sodium glucose cotransporter 2 (SGLT2) inhibitor, dapagliflozin, in obese insulin-resistant model
由: Krit Jaikumkao, et al.
出版: (2018)

Renal outcomes with sodium glucose cotransporter 2 (SGLT2) inhibitor, dapagliflozin, in obese insulin-resistant model
由: Krit Jaikumkao, et al.
出版: (2018)

Renal outcomes with sodium glucose cotransporter 2 (SGLT2) inhibitor, dapagliflozin, in obese insulin-resistant model
由: Krit Jaikumkao, et al.
出版: (2019)

Role of Gastrointestinal Microbiota on Kidney Injury and the Obese Condition
由: Wanchai K., et al.
出版: (2017)

Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes by Sodium-Glucose Cotransporter 2 Inhibitor Treatment: The FIDELITY Analysis
由: Anantharaman, Vathsala, et al.
出版: (2023)

Role of Gastrointestinal Microbiota on Kidney Injury and the Obese Condition
由: Keerati Wanchai, et al.
出版: (2018)

Role of Gastrointestinal Microbiota on Kidney Injury and the Obese Condition
由: Keerati Wanchai, et al.
出版: (2018)

The potential roles of chitosan oligosaccharide in prevention of kidney injury in obese and diabetic conditions
由: Prempree Sutthasupha, et al.
出版: (2020)

The role of transporter ectodomains in drug recognition and binding: Phlorizin and the sodium-glucose cotransporter
由: M. Raja, et al.
出版: (2018)

Diacerein alleviates kidney injury through attenuating inflammation and oxidative stress in obese insulin-resistant rats
由: Nuttawud Chueakula, et al.
出版: (2018)

Diacerein alleviates kidney injury through attenuating inflammation and oxidative stress in obese insulin-resistant rats
由: Nuttawud Chueakula, et al.
出版: (2018)

Diacerein alleviates kidney injury through attenuating inflammation and oxidative stress in obese insulin-resistant rats
由: Nuttawud Chueakula, et al.
出版: (2019)

Sodium-Glucose Cotransporter 2 Inhibition for the Prevention of Cardiovascular Events in Patients With Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis
由: Arnott, C., et al.
出版: (2021)

Dapagliflozin, a sodium-glucose co-transporter-2 inhibitor, slows the progression of renal complications through the suppression of renal inflammation, endoplasmic reticulum stress and apoptosis in prediabetic rats
由: Krit Jaikumkao, et al.
出版: (2018)

Dapagliflozin, a sodium-glucose co-transporter-2 inhibitor, slows the progression of renal complications through the suppression of renal inflammation, endoplasmic reticulum stress and apoptosis in prediabetic rats
由: Krit Jaikumkao, et al.
出版: (2019)

The roles of melatonin on kidney injury in obese and diabetic conditions
由: Sasivimon Promsan, et al.
出版: (2020)

Cost Utility of Sodium-Glucose Cotransporter 2 Inhibitors in the Treatment of Metformin Monotherapy Failed Type 2 Diabetes Patients: A Systematic Review and Meta-Analysis
由: Bhavani Shankara Bagepally, et al.
出版: (2020)

Potential mechanisms responsible for cardioprotective effects of sodium-glucose co-transporter 2 inhibitors
由: Sarayut Lahnwong, et al.
出版: (2018)

Cardiovascular outcomes with sodium–glucose cotransporter-2 inhibitors vs other glucose-lowering drugs in 13 countries across three continents: analysis of CVD-REAL data
由: Khunti, Kamlesh, et al.
出版: (2022)

Single-molecule AFM studies of substrate transport by using the sodium-glucose cotransporter SGLT1
由: Theeraporn Puntheeranurak, et al.
出版: (2018)

Effect of sodium-glucose cotransporter-2 (SGLT2) inhibitors on serum urate levels in patients with and without diabetes: a systematic review and meta-regression of 43 randomized controlled trials
由: Yip, Alicia Swee Yan, et al.
出版: (2022)

Effects of Sodium/Glucose Cotransporter 2 (SGLT2) Inhibitors on Cardiac Imaging Parameters: A Systematic Review and Meta-analysis of Randomized Controlled Trials
由: Wee, CF, et al.
出版: (2022)

Prebiotic prevents impaired kidney and renal Oat3 functions in obese rats
由: Keerati Wanchai, et al.
出版: (2018)

Prebiotic prevents impaired kidney and renal Oat3 functions in obese rats
由: Keerati Wanchai, et al.
出版: (2018)

Prebiotic prevents impaired kidney and renal Oat3 functions in obese rats
由: Keerati Wanchai, et al.
出版: (2019)

The additive effects of atorvastatin and insulin on renal function and renal organic anion transporter 3 function in diabetic rats
由: Laongdao Thongnak, et al.
出版: (2018)

Understanding The Role of Kidney in Glucose Balance Through Renal Sodium Glucose Co-Transporter
由: Agung Pranoto, NIDN. 0004015605
出版: (2016)

Alstiphyllanines E–H, picraline and ajmaline-type alkaloids from Alstonia macrophylla inhibiting sodium glucose cotransporter
由: Hiroko Arai, -, et al.
出版: (2010)

Is it time for class I recommendation for sodium-glucose cotransporter-2 inhibitors in heart failure with mildly reduced or preserved ejection fraction?: An updated systematic review and meta-analysis
由: Treewaree S.
出版: (2023)

Evaluating the Initiation of Sodium/Glucose Cotransporter 2 Inhibitors within 2 Weeks of an Acute Hospital Admission: A Systematic Review and Meta-Analysis of Nine Clinical Trials
由: Chieng, Jenny Hui Ling, et al.
出版: (2022)

Effects of Sodium-Glucose Cotransporter 2 on Amputation Events: A Systematic Review and Meta-Analysis of Randomized-Controlled Trials.
由: See, Ray Meng, et al.
出版: (2022)

Atorvastatin attenuates obese-induced kidney injury and impaired renal organic anion transporter 3 function through inhibition of oxidative stress and inflammation
由: Nattavadee Pengrattanachot, et al.
出版: (2020)

Atorvastatin attenuates obese-induced kidney injury and impaired renal organic anion transporter 3 function through inhibition of oxidative stress and inflammation
由: Nattavadee Pengrattanachot, et al.
出版: (2020)

Riceberry bran extract prevents renal dysfunction and impaired renal organic anion transporter 3 (Oat3) function by modulating the PKC/Nrf2 pathway in gentamicin-induced nephrotoxicity in rats
由: Arjinajarn P., et al.
出版: (2017)

Atorvastatin improves renal organic anion transporter 3 and renal function in gentamicin-induced nephrotoxicity in rats
由: Jaikumkao K., et al.
出版: (2017)

Functional characterization of sodium-carboxylate cotransporters in human hepatoma cell lines
由: Piyarat Srisawang
出版: (2023)

Roles of Obese-Insulin Resistance and Anti-Diabetic Drugs on the Heart with Ischemia-Reperfusion Injury
由: Apaijai,N., et al.
出版: (2015)

Roles of Obese-Insulin Resistance and Anti-Diabetic Drugs on the Heart with Ischemia-Reperfusion Injury
由: Apaijai,N., et al.
出版: (2015)